Mediwin Bio Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 40 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 0.03%
- Profit Growth -18.09%
- Ebitda 1.46%
- Net Worth 1356.23%
- Total Assets 6.87%
About Mediwin Bio Healthcare
Mediwin Bio Healthcare Private Limited (MBHPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 December 1984 and has a history of 40 years and one month. Its registered office is in Ahmedabad, Gujarat, India.
The Corporate was formerly known as Capit Formulations Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bhavin Patel and Harshal Patel serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85110GJ1984PTC007484
-
Company No.
007484
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Dec 1984
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Mediwin Bio Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhavin Patel
|
Director | 10-Dec-2016 | Current |
| Harshal Patel | Director | 20-Aug-2024 | Current |
Financial Performance of Mediwin Bio Healthcare.
Mediwin Bio Healthcare Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.03% increase. The company also saw a substantial fall in profitability, with a 18.09% decrease in profit. The company's net worth Soared by an impressive increase of 1356.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mediwin Bio Healthcare?
Unlock access to Mediwin Bio Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Medinej Pharmaceutical Private LimitedBhavin Patel is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mediwin Bio Healthcare?
Unlock and access historical data on people associated with Mediwin Bio Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mediwin Bio Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediwin Bio Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
